RecruitingPhase 3NCT04217512
Pantoprazole in Cisplatin Nephrotoxicity
Possible Protective Effect of Pantoprazole in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer
Sponsor
Sherief Abd-Elsalam
Enrollment
60 participants
Start Date
May 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Pantoprazole in Cisplatin Nephrotoxicity
Eligibility
Plain Language Summary
Simplified for easier understanding
This study is testing whether pantoprazole (a common over-the-counter stomach acid medication) can protect the kidneys from damage caused by cisplatin, a strong chemotherapy drug frequently used to treat head and neck cancers. Cisplatin is effective but can cause kidney injury as a side effect, and researchers want to see if this simple, widely available medication can reduce that risk.
**You may be eligible if...**
- You have been diagnosed with head and neck cancer
- You are scheduled to receive cisplatin chemotherapy as part of your treatment
**You may NOT be eligible if...**
- Your kidney function is already significantly reduced (GFR below 59 mL/min)
- You have diabetes
- Your liver enzymes are elevated more than 3 times above the normal upper limit
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPantoprazole low dose
Pantoprazole 0.6 mg/kg
DRUGPantoprazole high dose
Pantoprazole 1.6 mg\\kg
OTHERStandard hydration
Standard hydration alone
DRUGCisplatin
Cisplatin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04217512
Related Trials
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
NCT075320831 location
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
NCT063467821 location
STEP2 vs. Routine Early Palliative Care: Randomized Noninferiority Trial
NCT074466601 location
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT0632641123 locations
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
NCT066976004 locations